Skin allograft in the treatment of toxic epidermal necrolysis (TEN)

Dermatologic Surgery

Volumn 28, Issue 12, 2002, Pages 1173-1176

  Pianigiani, Elisa ^a   Ierardi, Francesca ^a   Taddeucci, Paolo ^a   Perotti, Roberto ^a   Biagioli, Maurizio ^a   Di Simplicio, Francesca Cherubini ^a   Andreassi, Andrea ^a   Fimiani, Michele ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALGESIA; ARTICLE; BODY SURFACE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SKIN ALLOGRAFT; SKIN DEFECT; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMPICILLIN; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; GLYCEROL; HUMANS; MALE; MIDDLE AGED; ORGAN PRESERVATION; RANITIDINE; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036950837     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2002.02119.x     Document Type: Article

References (27)

1. Revuz J. New advances in severe adverse drug reactions. Dermatol Clin 2001;19:697-709, ix.
2. Khoo AK, Foo CL. Toxic epidermal necrolysis in a burns centre: A 6-year review. Burns 1996;22:275-8.
3. Murphy JT, Purdue GF, Hunt JL. Toxic epidermal necrolysis. J Burn Care Rehabil 1997;18:417-20.
4. Honari S, Gibran NS, Heimbach DM, Gibbons J, Cain V, Engrav LH. Toxic epidermal necrolysis in elderly patients. J Burn Care Rehabilitation 2001;22:132-5.
5. Rzany B, Mockenhaupt M, Stocker U, et al. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with acquired immunodeficiency syndrome in Germany. Arch Dermatol 1993;129:1059.
6. Saiag PH, Caumes E, Chosidow O, et al. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 1992;26:567-74.
7. Strom BL, Carson JL, Halpern AC, et al. A population-based on study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol 1991;127:831-8.
8. McGee T, Munster A. Toxic epidermal necrolysis syndrome: Mortality rate reduced with early referral to regional burn center. Plast Reconstr Surg 1998;102:1018-22.
9. Roujeau JC. Treatment of severe drug eruptions. J Dermatol 1999;26:718-22.
10. Halebian P, Cordev VJ, Madden MR, et al. Improved burn center survival with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 1986;204:503.
11. Rzany B, Schmitt H, Schopf E. Toxic epidermal necrolysis in patients receiving glucocorticosteroids. Acta Derm Venereol 1991;71:171-2.
12. Egan CA, Grant WJ, Morris SE, et al. Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J Am Acad Dermatol 1999;40:458-61.
13. Heng MC, Allen SG. Efficacy of cyclophosphamide in toxic epidermal necrolysis: Clinical and pathophysiologic aspects. J Am Acad Dermatol 1991;25:778-86.
14. Hewitt J, Ormerod AD. Toxic epidermal necrolysis treated with cyclosporin. Clin Exp Dermatol 1992;17:264-5.
15. Viard I, Wehrli P, Bulloni R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-3.
16. Heimbach DM, Engrav LH, Marvin JA, Harnar TJ, Grube BJ. Toxic epidermal necrolysis. A step forward in treatment. JAMA 1987;257:2171-5.
17. Garcia Bernal FJ, Torrero V, Regalado J, Ferdinandez Samaniego F, Gabilondo FJ. Lyell's syndrome management in a burn unit. Coverage with cryopreserved allograft. Ann Burns Fire Disasters 1998;11:217-21.
18. Kucan J. Use of biobrane in the treatment of toxic epidermal necrolysis. J Burn Care Rehabil 1995;16:324-8.
19. Michaels MG. Infectious concerns of cross-species transplantation: Xenozoonoses. World J Surg 1997;21:968-74.
20. Daar AS. Ethics of xenotransplantation: Animal issues, consent, and likely transformation of transplant ethics. World J Surg 1997;21:975-82.
21. Seah CS. Skin graft and skin equivalent in burns. Ann Acad Med 1992;22:685-8.
22. Bradley T, Brown RE, Kucan JO, Smoot EC III, Hussmann J. Toxic epidermal necrolysis, a review and report of the successful use of Biobrane for early wound coverage. Ann Plast Surg 1995;35:124-32.
23. Pianigiani EP, Taddeucci S. Mancini, et al. Wound healing in leg ulcers treated by combined skin allograft and autograft. J Invest Dermatol 2001;117:544.
24. van Baare J, Cameron PU, Vardaxis N, et al. The 1998 Lindberg award. Comparison of glycerol preservation with cryopreservation methods on HIV-1 inactivation. J Burn Care Rehabil 1998;19:494-500.
25. Kearney JN. Quality issues in skin banking: A review. Burns 1998;24:299-305.
26. Ninnemann JL, Fisher JC, Frank HA. Clinical skin banking a simplified system for processing, storage and retrieval of human allografts. J Trauma 1978;18:723-5.
27. White MJ, Whalen JD, Gould JA, Brown GL, Polk HC. Procurement and transplantation of colonized cadaver skin. Am Surg 1991;57:402-7.